Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS

• Hoofdauteurs: Xiang Zhou (Auteur), Xiaofei Ye (Auteur), Xiaojing Guo (Auteur), Dongxu Liu (Auteur), Jinfang Xu (Auteur), Fangyuan Hu (Auteur), Yinghong Zhai (Auteur), Yongqing Gao (Auteur), Xiao Xu (Auteur), Ziwei Dong (Auteur), Jia He (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Sodium-glucose co-transporter-2 inhibitors (SGLT2is) are widely used in clinical practice for their demonstrated cardiorenal benefits, but multiple adverse events (AEs) have been reported. We aimed to describe the distribution of SGLT2i-related AEs in different systems and identify impor...